Founded in 2005, Graftys develops, manufactures and markets patented synthetic bone biomaterials, in particular new generations of resorbable calcium-phosphate cements, for reconstructive orthopedic surgery. The Company’s products are commercialized in more than 25 countries, including Europe and the United States of America, through distribution partnership. The objective of the Company is to expand the Company product lines by offering new versions of existing products and new products with enhanced regenerative properties. The Company is based in Belgium (Wallonia) and France (Nantes and Aix-En-Provence).
| Website | http://www.graftys.com |
| Revenue | $5.1 million |
| Employees | 13 (10 on RocketReach) |
| Founded | 2005 |
| Phone | +1 508-478-8900 |
| Fax | (847) 557-9089 |
| Industry | Retail, Medical Devices, Biotechnology, Science and Engineering, Fitness, Sports, Wellness, Health Care |
| Web Rank | 10 Million |
| Keywords | Orthopedic Surgery, Bone Graft Substitutes, Reconstructive Surgery, Bone Regeneration, Bone Repair, Bone Healing, Orthopedic Biomaterials, Biomaterials, Orthopedic Implants, Regenerative Medicine, Calcium Phosphate, Tissue Engineering, Biocompatible Materials, Musculoskeletal, Trauma Surgery, Medical Devices, Drug Delivery |
| Competitors | Zimmer Biomet, Stryker, Medtronic, Johnson & Johnson, Smith+Nephew, Baxter International Inc., Impulse Monitoring, CONMED Corporation, DePuy Synthes, Orthofix +29 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Graftys employee's phone or email?
The Graftys annual revenue was $5.1 million in 2026.
Roxanne MacIas is the Chief Commercial Officer – Strategic Advisory of Graftys.
10 people are employed at Graftys.
The NAICS codes for Graftys are [5417, 541713, 541, 54, 54171].
The SIC codes for Graftys are [87, 873].